封面
市場調查報告書
商品編碼
1461343

合成生物學市場:按產品、按技術、按最終用戶、按地區

Synthetic Biology Market, By Product, By Technology, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

合成生物學市場預計到2024年將達到178.8億美元,預計到2031年將達到730.8億美元,2024年至2031年的年複合成長率為22.3%。

報告範圍 報告詳情
基準年 2023年 2023/2024年市場規模 178.8億美元
實際資料 2019-2023 預測期 2024-2031
預測期2023/2024-2030/2031年複合成長率 22.30% 2030/2031 年預測值 730.8億美元
按地區分類的合成生物市場佔有率 (%) (2024)
合成生物市場-IMG1

合成生物學是將工程原理應用於生物學的新興領域。此部分涉及新型人工生物途徑、生物體、裝置的設計和構建,或現有自然生物系統的重新設計。合成生物學的主要發展包括燃料、化學品和材料的先進生物製造技術的開發,以及用於農業、製藥和環境解決方案的人造生物體的開發。研究人員正在致力於開發人工生物系統,以實現更有效、更環保的生產過程。 DNA序列測定、基因組裝和編輯技術的進步正在推動這一領域的快速發展,有可能解決醫學、能源和環境領域許多緊迫的全球挑戰。

市場動態:

全球合成生物學市場的促進因素包括該領域研發資金和投資的增加、DNA定序和基因編輯技術的進步、生物製藥需求的不斷成長以及代謝工程等技術的發展。正在製定行業標準,以確保合成生物學的負責任和安全應用。然而,有關基因改造生物的監管問題和倫理問題可能會限制市場成長。合成生物學描述了應對多個領域挑戰的機會,包括藥物發現、工業生物製造和環境修復。開拓商業應用、國際合作研究以及提高 DNA 合成和基因組工程的成本效率將支持市場擴張。

本研究的主要特點

  • 該報告對全球合成生物學市場進行了詳細分析,並提出了以2023年為基準年的預測期(2024-2031)的市場規模和年複合成長率(CAGR%)。
  • 它還強調了各個細分市場的潛在收益成長機會,並說明了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 該報告根據公司亮點、產品系列、主要亮點、業績和策略等參數,介紹了全球合成生物學市場的主要企業。
  • 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 合成生物學全球市場報告迎合了該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球合成生物學市場的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件

第2章 市場概況

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • 市場機會藍圖

第 3 章主要見解

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 影響分析
  • PEST分析
  • 波特分析
  • 技術進步
  • 合併、收購和合作場景
  • 最近的產品核可
  • 進出口分析
  • 監管場景
  • 價格分析
  • COVID-19 影響分析
  • 製造能力
  • 經銷商狀況
  • 投資金籌措
  • 品牌映射
  • 比賽簡介
  • 企業定位分析
  • 熱圖分析

第4章全球合成生物市場,依產品,2019-2031

  • 介紹
  • 寡核苷酸
  • 酵素
  • 合成細胞
  • 底盤有機體
  • 其他

第5章全球合成生物市場,依技術分類,2019-2031

  • 介紹
  • 基因組工程
  • PCR技術
  • 生物加工技術
  • 新一代定序技術
  • 生物資訊學
  • 奈米科技
  • 其他

第6章 全球合成生物市場,依最終使用者分類,2019-2031

  • 介紹
  • 製藥公司
  • 生技公司
  • 首席行銷長和首席研究官
  • 其他

第7章2019-2031年全球合成生物市場(按地區)

  • 介紹
  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 東南亞國協
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • 波灣合作理事會
  • 以色列
  • 其他中東地區
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第8章 競爭格局

  • Synbio Technologies
  • Merck KGaA
  • Agilent Technologies Inc.
  • GenScript
  • Amyris
  • Eurofins Genomics GmbH
  • Integrated DNA Technologies Inc.
  • Codexis Inc.
  • EnBiotix Inc.
  • Synthego
  • New England Biolabs (UK) Ltd.
  • Scarab Genomics LLC
  • Genomatica Inc.
  • Novonesis Group
  • Bota Bio
  • Creative Biogene
  • Illumina, Inc.

第9章 盛衰

  • 繁榮與衰落
  • 綜合機會圖

第10章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI112

The synthetic biology market is estimated to be valued at USD 17.88 Bn in 2024 and is expected to reach USD 73.08 Bn by 2031, growing at a compound annual growth rate (CAGR) of 22.3% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 17.88 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 22.30% 2030/2031 Value Projection: US$ 73.08 Bn
Synthetic Biology Market Share (%), By Region, 2024
Synthetic Biology Market - IMG1

Synthetic biology is an emerging field that applies engineering principles to biology. It involves the design and construction of novel artificial biological pathways, organisms or devices or the re-design of existing natural biological systems. Some key applications of synthetic biology include development of advanced biomanufacturing techniques for fuels, chemicals and materials as well as development of engineered organisms for agriculture, pharmaceuticals and environmental solutions. Researchers are working towards developing engineered biological systems for more effective and environment-friendly production processes. Advancements in DNA sequencing, gene assembly, and editing techniques have enabled rapid progress in the field with the potential to address many pressing global challenges in healthcare, energy, and environment.

Market Dynamics:

The global synthetic biology market is driven by factors such as increasing R&D funding and investment in the field, advancements in DNA sequencing and gene editing technologies, rising demand for biopharmaceuticals, and development of techniques like metabolic engineering. Industry standards are being developed to ensure the responsible and safe application of synthetic biology. However, regulatory issues relating to genetically engineered organisms and ethical concerns could potentially restrain the market growth. Synthetic biology offers opportunities to address challenges in several sectors like drug discovery, industrial biomanufacturing, and environmental remediation. Development of commercial applications, international collaborations, and improved cost efficiencies in DNA synthesis and genome engineering will support market expansion.

Key Features of the Study:

  • This report provides an in-depth analysis of the global synthetic biology market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global synthetic biology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes Thermo Fisher Scientific, Synbio Technologies, Merck KGaA, Agilent Technologies Inc., GenScript, Amyris, Eurofins Genomics GmbH, Integrated DNA Technologies Inc., Codexis Inc., EnBiotix Inc., Synthego, New England Biolabs (UK) Ltd., Scarab Genomics LLC , Genomatica Inc., Novonesis Group, Bota Bio, Creative Biogene, and Illumina, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global synthetic biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global synthetic biology market.

Market Segmentation

  • Product:
    • Oligonucleotides
    • Enzymes
    • Synthetic Cells
    • Chassis Organism
    • Others
  • Technology:
    • Genome Engineering
    • PCR Technology
    • Bioprocessing Technology
    • NGS Technology
    • Bioinformatics
    • Nanotechnology
    • Others
  • End User:
    • Pharmaceutical Companies
    • Biotechnology Companies
    • CMO & CRO
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Thermo Fisher Scientific
    • Synbio Technologies
    • Merck KGaA
    • Agilent Technologies Inc.
    • GenScript
    • Amyris
    • Eurofins Genomics GmbH
    • Integrated DNA Technologies Inc.
    • Codexis Inc.
    • EnBiotix Inc.
    • Synthego
    • New England Biolabs (UK) Ltd.
    • Scarab Genomics LLC
    • Genomatica Inc.
    • Novonesis Group
    • Bota Bio
    • Creative Biogene
    • Illumina, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Technology
    • Market Snapshot, By End User
    • Market Snapshot, By Region
    • Market Scenario - Conservative, Likely, Opportunistic
  • Market Opportunity Map

3. Key Insights

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Pest Analysis
  • Porters Analysis
  • Technological Advancement
  • Merger, Acquisition and Collaboration Scenario
  • Recent Product Approvals
  • Import-Export Analysis
  • Regulatory Scenario
  • Pricing Analysis
  • COVID-19 Impact Analysis
  • Manufacturing Capacities
  • Distributors Landscape
  • Investments & Funding
  • Brand Mapping
  • Competitive Snapshot
  • Company Positioning Analysis
  • Heat Map Analysis

4. Global Synthetic Biology Market, By Product, 2019 - 2031 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2024, 2027 & 2031
    • Market Y-o-Y Growth Comparison (%), 2019 - 2031
    • Segment Trends
  • Oligonucleotides, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Enzymes, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Synthetic Cells, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Chassis Organism, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Others, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Synthetic Biology Market, By Technology, 2019 - 2031 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2024, 2027 & 2031
    • Market Y-o-Y Growth Comparison (%), 2019 - 2031
    • Segment Trends
  • Genome Engineering, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • PCR Technology, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Bioprocessing Technology, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • NGS Technology, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Bioinformatics, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Nanotechnology , 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Others, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Synthetic Biology Market, By End User, 2019 - 2031 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2024, 2027 & 2031
    • Market Y-o-Y Growth Comparison (%), 2019 - 2031
    • Segment Trends
  • Pharmaceutical Companies, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Biotechnology Companies, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • CMO & CRO, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)
  • Others, 2019 - 2031(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Synthetic Biology Market, By Region, 2019 - 2031 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
    • Market Y-o-Y Growth Comparison (%), 2024 - 2031, (US$ Billion)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Technology, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Technology, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest Of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Technology, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Asean
  • Rest Of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Technology, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Technology, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
  • GCC
  • Israel
  • Rest Of The Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Technology, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By End User, 2019 - 2031, (US$ Billion)
    • Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
  • South Africa
  • North Africa
  • Central Africa

8. Competitive Landscape

  • Competitive Snapshot
  • What Market Participants are Saying?
  • Competitive Dashboard
  • Company Market Share Analysis, 2024 - Global
  • Company Profiles - Global Synthetic Biology Market
  • Thermo Fisher Scientific
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Synbio Technologies
  • Merck KGaA
  • Agilent Technologies Inc.
  • GenScript
  • Amyris
  • Eurofins Genomics GmbH
  • Integrated DNA Technologies Inc.
  • Codexis Inc.
  • EnBiotix Inc.
  • Synthego
  • New England Biolabs (UK) Ltd.
  • Scarab Genomics LLC
  • Genomatica Inc.
  • Novonesis Group
  • Bota Bio
  • Creative Biogene
  • Illumina, Inc.

9. Wheel of Fortune

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact